Vimarsana
Biggest News Aggregation in the World

Page 2 - Whale Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Whale Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Whale Technology Today - Breaking & Trending Today

Very Clean Planet Partners with BravoWhale to Launch the - Vimarsana News

Very Clean Planet Partners with BravoWhale to Launch the

HONG KONG, April 20, 2022 (GLOBE NEWSWIRE) -- Very Clean Planet (VCP) today announced the launch of its global digital engagement hub for carbon asset...

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials - Vimarsana News

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials

/PRNewswire/ -- Novaliq GmbH, 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd. today announced the establishment of Dermaliq Therapeutics,...

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials - Vimarsana News

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials

/PRNewswire/ -- Novaliq GmbH, 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd. today announced the establishment of Dermaliq Therapeutics,...

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials - Vimarsana News

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials

- Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq - Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials - Vimarsana News

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials

- Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq - Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative technology outside eye care - 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd join as new investors - Proceeds will be used for three Phase 1/2a clinical development programs in...